Influenza A viruses pose a serious threat to public health. The nucleoprotein (NP) of an influenza virus is a highly conserved protein involved in the transcription, replication and packaging of the viral genome, influencing the virulence of the virus within the host.
This invention is a hybridoma that secrets monoclonal antibodies that can broadly-react against the NP of influenza viruses. The antibodies, designated G20, A40 and A60, were specifically raised against the NP of the H3N2 virus A/Minnesota/11/2010.
|Potential Commercial Applications||Competitive Advantages|
Development Stage: Research reagent
Inventors: Hongquan Wan
Product Area: Bioassay, diagnostics, vaccine
FDA Reference No:E-2018-007
Bill Ronnenberg, MS, JD/MIP
FDA Technology Transfer Program